Ammar Al-Chalabi, a neurologist at Kings College, London, wants to repurpose Triumeq, an HIV drug, to fight motor neurone disease.
Udokotela wezemizwa e-Kings College eLandani, u-Ammar Al-Chalabi, ufuna ukuvuselela inhloso ye-Triumeq, ikhambi leSandulela-ngculaza, ukulwa nesifo semizwa.